ADUS Form 144: Restricted Stock Sale of 522 Shares on NASDAQ

Rhea-AI Filing Summary

Addus HomeCare (ADUS) filed a Form 144 reporting a proposed resale of 522 common shares through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $56,898 and 18,407,239 shares outstanding. The filing lists an approximate sale date of 08/08/2025.

The securities were acquired as restricted stock from the issuer on 06/12/2025 with payment recorded the same day, and the filer reports "Nothing to Report" for sales in the past three months. This Form 144 is a notice of intended resale under Rule 144 and includes the seller's representation that they are not aware of any undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Small, disclosed resale of recently acquired restricted shares; transaction size is immaterial versus outstanding shares.

The filing documents an intended sale of 522 Addus common shares valued at $56,898, to be executed through Morgan Stanley Smith Barney LLC on NASDAQ. The shares were acquired as restricted stock on 06/12/2025 and the planned sale date is 08/08/2025. No sales in the prior three months were reported. For investors this reads as a procedural Rule 144 disclosure of a small resale rather than a material corporate development.

Corporate Governance Expert

TL;DR: Disclosure appears procedurally compliant; recent restricted grant and quick resale noted with no evident governance red flags.

The form provides broker details and the mandatory seller representation about no undisclosed material adverse information. The amount—522 shares against 18,407,239 outstanding—is negligible in percentage terms, and no other insider dispositions were reported for the prior three months. From a governance perspective this looks like routine compliance with Rule 144 reporting requirements rather than signaling broader governance or financial issues.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	522	56898.00	18407239	08/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/12/2025	Restricted Stock	Issuer			522	06/12/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ADUS Form 144 disclose?

The filing discloses a proposed sale of 522 common shares of Addus HomeCare (ADUS) with an aggregate market value of $56,898 on NASDAQ.

Who is the broker arranging the sale listed on the Form 144 for ADUS?

The broker is listed as Morgan Stanley Smith Barney LLC Executive Financial Services (address shown in the filing).

When is the approximate date of sale for the ADUS shares?

The approximate date of sale is listed as 08/08/2025.

How were the ADUS shares being sold acquired?

The 522 shares were acquired as restricted stock from the issuer on 06/12/2025 with payment recorded that same day.

Were any ADUS securities sold by the seller in the past three months?

No. The filing reports "Nothing to Report" for securities sold during the past three months.